Related Experiment Video
Updated: Jun 24, 2026

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
Abdominoplasty in obese and in morbidly obese patients
M Murshid1, K N Khalid, A Shakir
1Plastic & hand surgery unit, HMC Rumaila Hospital, Doha, Qatar. murshidmohd@hotmail.com
Abstract:
This study aims to determine if morbid obesity increases morbidity in abdominoplasty. Upon examining 200 patients, 100 morbidly obese and 100 overweight and obese, it was found that there is no difference in the complication rate between the two categories. It was also found that, when compared to global rates of complication, there is no difference in the rate of complication of dermolipectomy as a whole in non-obese patients. However, co-morbid diseases are more correlated to complication. This article concludes with a remark that although morbid obesity should not preclude abdominoplasty, patients benefit from the operation even when it is performed as a functional operation and not as a cosmetic procedure.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
